Edition:
India

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

48.67USD
27 Jun 2017
Change (% chg)

$-0.24 (-0.49%)
Prev Close
$48.91
Open
$48.99
Day's High
$49.12
Day's Low
$48.65
Volume
1,253,657
Avg. Vol
2,029,519
52-wk High
$49.59
52-wk Low
$36.76

ABT.N

Chart for ABT.N

About

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded... (more)

Overall

Beta: 1.57
Market Cap(Mil.): $84,455.69
Shares Outstanding(Mil.): 1,735.27
Dividend: 0.26
Yield (%): 2.18

Financials

  ABT.N Industry Sector
P/E (TTM): 54.03 13.69 17.46
EPS (TTM): 0.90 -- --
ROI: 2.93 -6.93 -5.20
ROE: 5.35 -6.40 -4.44

BRIEF-Abbott sets quarterly dividend of $0.265 per share

* Sets quarterly dividend of $0.265 per share Source text for Eikon: Further company coverage:

09 Jun 2017

BRIEF-Alere Q4 loss per share $1.38 from continuing operations

* Alere files form 10-k, reports fourth quarter and full year 2016 financial results

06 Jun 2017

BRIEF-Abbott reports CE Mark for tacticath contact force ablation catheter

* Abbott announces CE Mark for tacticath™ contact force ablation catheter, sensor enabled™

09 May 2017

BRIEF-Abbott announces CE Mark and first use of the world's first smartphone compatible insertable cardiac monitor

* Abbott announces CE mark and first use of the world's first smartphone compatible insertable cardiac monitor

08 May 2017

MEDIA-India govt rejects Abbott, Medtronic applications to withdraw stents - PTI in Mint

- Note: Reuters has not verified this story and does not vouch for its accuracy

27 Apr 2017

CORRECTED-OFFICIAL-China's richest man deepens sports foray with global marathons deal

BEIJING, April 26 China's Dalian Wanda Group, controlled by the country's richest man Wang Jianlin, has signed a deal to sponsor races with the world's top organizer, Abbott World Marathon Majors (WMM), the latest move by Wanda to expand its global sports business.

26 Apr 2017

BRIEF-Abbott Laboratories develops 2 new science-based nutrition drinks for patients undergoing surgery

* Abbott Laboratories - developed two new science-based nutrition drinks for patients undergoing surgery Source text for Eikon: Further company coverage:

26 Apr 2017

China's richest man deepens sports foray with global marathons deal

BEIJING China's Dalian Wanda Group, controlled by the country's richest man Wang Jianlin, has signed a deal to sponsor races with the world's top organizer, Abbott World Marathon Majors (WMM), the latest move by Wanda to expand its global sports business.

26 Apr 2017

MEDIA-Abbott, Medtronic, Boston Scientific to recall new generation stents from India - Economic Times

- Note: Reuters has not verified this story and does not vouch for its accuracy

24 Apr 2017

Abbott sees Alere as challenging 'fixer-upper' after revised deal

Abbott Laboratories said it was looking to close the recently revised deal to buy Alere Inc in the coming months, calling the diagnostics company "a bit of a fixer-upper".

19 Apr 2017

More From Around the Web

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $135.01 -1.33
Pfizer Inc. (PFE.N) $33.77 -0.27
Novartis AG (NOVN.S) CHF82.30 -0.50
Merck & Co., Inc. (MRK.N) $65.54 -0.38
Sanofi SA (SASY.PA) €86.27 -1.36
AstraZeneca plc (AZN.L) 5,304.00 -43.00
GlaxoSmithKline plc (GSK.L) 1,684.00 -13.50
Eli Lilly and Co (LLY.N) $83.04 -1.24
Amgen, Inc. (AMGN.OQ) $170.85 --
Boston Scientific Corporation (BSX.N) $27.81 +0.09

Earnings vs. Estimates